Algert Global’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Algert Global's KNSA Position: Q3 2026 in Review
Algert Global opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 37,930 shares worth $2.83M. The stake represents 0.03% of the portfolio and ranks #728 among its holdings. This is a return to the name: Algert Global previously reported a position in KNSA as recently as Q3 2025.
Algert Global first reported a position in KNSA in Q4 2018 and has held it in 13 quarters since. The position peaked at $6.42M in Q2 2025. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Algert Global held 37,930 shares of Kiniksa Pharmaceuticals worth $2.83M as of Q3 2026.
- Kiniksa Pharmaceuticals was a new Algert Global position in Q3 2026.
- Kiniksa Pharmaceuticals made up 0.03% of Algert Global's portfolio in Q3 2026, its #728 holding.
- Algert Global first reported a position in Kiniksa Pharmaceuticals in Q4 2018 and has held it in 13 quarters since.
- Algert Global's Kiniksa Pharmaceuticals position peaked at $6.42M in Q2 2025.
- 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Algert Global's 13F filing for Q3 2026, filed 17 Nov 2026.